The province reported 2 new deaths, 48 new cases of COVID-19 Monday along with 79 recoveries.

There are 76 people in hospital, the lowest number of hospitalizations since November 18, 2020, and 11 people are in intensive care.

The South Central Zone is reporting three new cases, Regina is reporting 15 new cases, 10 new cases in the North Central Zone, Saskatoon is reporting six new cases, 5 new cases in the Far North West, North West is reporting three new cases, two new cases in the Central West and the South East and Far North East are reporting one new case.

711 cases are considered active in the province and 35 of those are located in the sub-region 'south-central 2' which is made up of Moose Jaw and the surrounding area.

Saskatchewan has now entered Step Two of re-opening, with in-person gathering limits increasing across a number of sectors and for private gatherings.

The full implementation of Step 3 of the Re-Opening Roadmap will occur on Sunday, July 11.

That means that as of Sunday, July 11, all public health orders will be removed.

Vaccines Reported

Effective today, vaccine reporting numbers have returned to a 48-hour reporting period and thus will appear lower today.  The vaccine administration reporting timeline was adjusted to a 24-hour period Friday, Saturday and Sunday in order to provide the most up to date information to support a decision on the ability to move to Step 3 of the Re-Open Roadmap.

As of end of day Saturday, June 19, there were an additional 961 vaccinations administered in Saskatchewan, bringing the total number of vaccines administered in the province to 998,779.

The additional 961 doses of COVID-19 vaccine reported today were administered to residents living in the following zones: Far North West, 35; Far North Central, 2; Far North East, 25; North West, 11; North Central, 53; North East, 42; Saskatoon, 236; Central West, 15; Central East, 58; Regina, 343; South West, 15; South Central, 24; and South East, 70.  There were 32 doses administered with zone of residence pending.

Eighty per cent of those over the age of 40+ have received their first dose.  Seventy-four per cent of those 30+ have received their first dose.  Seventy per cent of those 18+ have received their first dose, while sixty-nine per cent of those 12+ have also received their first dose.